GRI - GRI Bio, Inc.
1.67
-0.170 -10.180%
Share volume: 366,944
Last Updated: 04-24-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$1.84
-0.17
-0.09%
View ratios
| Fiscal Date | 12-31-2024 | |
|---|---|---|
| Fiscal Quarter | Q4 2024 | |
| Report Date | 03-14-2025 | |
| Assets | ||
| Total Assets | 5.739 M | |
| Current Assets | 5.615 M | |
| Inventories | 0.000 | |
| Other Current Assets | 0.000 | |
| Short Term Investments | 0.000 | |
| Total Receivables | 0.000 | |
| Current Cash | 5.028 M | |
| Total Non-current Assets | 0.000 | |
| Property Plant Equipment | 4.000 K | |
| Other Assets | 120.000 K | |
| Intangible Assets | 0.000 | |
| Goodwill | 0.000 | |
| Liabilities and shareholders’ equity | ||
| Total Liabilities and shareholders’ equity | 5.739 M | |
| Total liabilities | 1.707 M | |
| Total current liabilities | 1.636 M | |
| Accounts Payable | 897.000 K | |
| Other liabilities | 71.000 K | |
| Current long term debt | 0.000 | |
| Long term debt | 0.000 | |
| Other liabilities | 71.000 K | |
| Minority interest | 0.000 | |
| Total Shareholder equity | 4.032 M | |
| Common stock | 43.772 M | |
| Retained earnings | -39.740 M |
